Bristol Myers Squibb (BMY) Change in Taxes (2016 - 2025)
Historic Change in Taxes for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to $887.0 million.
- Bristol Myers Squibb's Change in Taxes rose 35488.51% to $887.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $441.0 million, marking a year-over-year increase of 23086.05%. This contributed to the annual value of -$1.3 billion for FY2024, which is 10895.52% down from last year.
- According to the latest figures from Q3 2025, Bristol Myers Squibb's Change in Taxes is $887.0 million, which was up 35488.51% from -$621.0 million recorded in Q2 2025.
- Bristol Myers Squibb's Change in Taxes' 5-year high stood at $1.0 billion during Q4 2023, with a 5-year trough of -$2.1 billion in Q2 2023.
- Over the past 5 years, Bristol Myers Squibb's median Change in Taxes value was -$46.0 million (recorded in 2021), while the average stood at -$212.1 million.
- In the last 5 years, Bristol Myers Squibb's Change in Taxes plummeted by 222272.73% in 2021 and then skyrocketed by 35488.51% in 2025.
- Quarter analysis of 5 years shows Bristol Myers Squibb's Change in Taxes stood at -$222.0 million in 2021, then plummeted by 401.35% to -$1.1 billion in 2022, then skyrocketed by 193.8% to $1.0 billion in 2023, then crashed by 88.41% to $121.0 million in 2024, then soared by 633.06% to $887.0 million in 2025.
- Its Change in Taxes was $887.0 million in Q3 2025, compared to -$621.0 million in Q2 2025 and $54.0 million in Q1 2025.